LOVO-CEL
Live / Registered — Registered (as of 30 Aug 2022)
What this means for you
Registered since 30 Aug 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Aug 2028: the §71 affidavit of use).
Record
- Serial number
- 79316992
- Registration number
- 6829776
- Mark type
- Word mark
- Filed
- 22 Apr 2021
- Published for opposition
- 14 Jun 2022
- Registered
- 30 Aug 2022
- Next maintenance filing
- §71 affidavit of use, due by 30 Aug 2028 (grace period to 28 Feb 2029)
- Attorney of record
- Christopher K. Albert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for treatment of genetic diseases, namely, sickle cell disease
Owner
- Genetix Biotherapeutics Inc., US
- Genetix Biotherapeutics, Inc., US
- bluebird bio, Inc., DE, US
- bluebird bio, Inc., DE, US
- bluebird bio, Inc., DE, US
- Bluebird Bio (UK) Ltd., GB
Prosecution history
- 24 Sept 2026 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 18 Dec 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Sept 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Dec 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 04 Jan 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 09 Dec 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 09 Dec 2022 — FINAL DISPOSITION PROCESSED
- 30 Nov 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Aug 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB